<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1d1" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher">REMEDIUM</journal-id><journal-title-group><journal-title>REMEDIUM</journal-title></journal-title-group><issn publication-format="print">1561-5936</issn><issn publication-format="electronic">2658-3534</issn><publisher><publisher-name>Joint-Stock Company Chicot</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1328</article-id><article-id pub-id-type="doi">10.21518/1561-5936-2018-11-64-69</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Monthly review: production, investment, finance</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Romanova</surname><given-names>Svetlana</given-names></name><bio></bio><email>noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff id="aff-1">Remedium</aff><pub-date date-type="epub" iso-8601-date="2018-12-11" publication-format="electronic"><day>11</day><month>12</month><year>2018</year></pub-date><issue>11</issue><fpage>64</fpage><lpage>69</lpage><history><pub-date date-type="received" iso-8601-date="2022-03-18"><day>18</day><month>03</month><year>2022</year></pub-date></history><permissions><copyright-statement>Copyright © 2018,</copyright-statement><copyright-year>2018</copyright-year></permissions><abstract>Performance analysis of industry enterprises is conducted using the national statistics reports: Form P-1 urgent (monthly), Form No. P-2 «Information on Investments in Non-Financial Assets» (quarterly), Form No. P-3 «Information on Company Financial Status» (monthly).</abstract><kwd-group xml:lang="en"><kwd>drugs</kwd><kwd>medical equipment</kwd><kwd>medical devices</kwd><kwd>pharmaceutical industry</kwd><kwd>medical industry</kwd><kwd>enterprises</kwd><kwd>analysis</kwd><kwd>manufacture</kwd><kwd>investments</kwd><kwd>finance</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>лекарственные средства</kwd><kwd>медицинская техника</kwd><kwd>медицинские изделия</kwd><kwd>фармацевтическая промышленность</kwd><kwd>медицинская промышленность</kwd><kwd>предприятия</kwd><kwd>анализ</kwd><kwd>инвестиции</kwd><kwd>финансы</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Романова С.А. Инвестиционная активность предприятий отрасли: 1 полугодие 2017 год. Ремедиум, 2017; 11: 65-68</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Захарова В.М., Романова С.А. Инвестиции в развитие медицинской промышленности. Лучше мало, чем ничего. Ремедиум, 2000; 10: 20-27.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Романова С.А. Финансовые результаты фармотрасли за 1 полугодие 2017 года. Ремедиум, 2017; 11: 62-65</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Крейнина М.Н. Анализ финансового состояния и инвестиционной привлекательности акционерных обществ в промышленности, строительстве и торговле. М., 1994.</mixed-citation></ref></ref-list></back></article>
